| Entry |
|
|---|
| Name |
Tramazoline hydrochloride (JAN/USAN);
Towk (TN) |
|---|
| Formula |
C13H17N3. HCl
|
|---|
| Exact mass |
251.1189
|
|---|
| Mol weight |
251.7551
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
| Therapeutic category: | 1324 |
| Product (DG01033): | D01347<JP> |
|
|---|
| Efficacy |
Vasoconstrictor, alpha-Adrenergic receptor agonist |
|---|
| Comment |
Imidazoline derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AA Sympathomimetics, plain
R01AA09 Tramazoline
D01347 Tramazoline hydrochloride (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
132 Otic and nasal agents
1324 Otolaryngologic vasoconstrictors
D01347 Tramazoline hydrochloride (JAN/USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D01347 Tramazoline hydrochloride (JAN/USAN) <JP>
ADRA2
D01347 Tramazoline hydrochloride (JAN/USAN) <JP>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 X Cl 29.8200 -27.7900
2 C1x C 21.7700 -26.2500
3 C1x C 21.7700 -27.6500
4 C1x C 22.9824 -28.3500
5 C8y C 24.1949 -27.6500
6 C8y C 24.1949 -26.2500
7 C1x C 22.9824 -25.5500
8 C8x C 25.4073 -28.3500
9 C8x C 26.6197 -27.6500
10 C8x C 26.6197 -26.2500
11 C8y C 25.4073 -25.5500
12 N1b N 25.4073 -24.1500
13 C2y C 26.6218 -23.4488
14 N1x N 27.9323 -23.8800
15 C1x C 28.7495 -22.7673
16 C1x C 27.9438 -21.6463
17 N2x N 26.6286 -22.0661
BOND 18
1 2 3 1
2 3 4 1
3 4 5 1
4 5 6 1
5 6 7 1
6 2 7 1
7 5 8 2
8 8 9 1
9 9 10 2
10 10 11 1
11 6 11 2
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 13 17 2
|
|---|
